US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ENGENE HOLDINGS INC C/WTS 31/10/2028 (TO PUR COM) CL A

3.39

-0.1750-4.91%

Volume:16.05K

Turnover:54.10K

Market Cap:173.25M

PE:-1.48

High:3.48

Open:3.48

Low:3.35

Close:3.57

52wk High:4.20

52wk Low:0.5100

Shares:51.11M

Float Shares:51.11M

Volume Ratio:5.33

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.2947

ROE:-53.28%

ROA:-28.90%

PB:1.03

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

ENGENE HOLDINGS INC C/WTS 31/10/2028 (TO PUR COM) CL A

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.engene.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ENGNW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ENGNW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENGNW\",,,,,undefined,":{"symbol":"ENGNW","market":"US","secType":"STK","nameCN":"ENGENE HOLDINGS INC C/WTS 31/10/2028 (TO PUR COM) CL A","latestPrice":3.39,"timestamp":1772139600000,"preClose":3.565,"halted":0,"volume":16046,"delay":0,"changeRate":-0.04908835904628326,"floatShares":51105201,"shares":51105201,"eps":-2.2947,"marketStatus":"Post-Mkt","change":-0.175,"latestTime":"02-26 18:57:17 EST","open":3.48,"high":3.48,"low":3.35,"amount":54098.2825,"amplitude":0.036466,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.2947,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772154000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":3.565,"volumeRatio":5.329835},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENGNW\",,,,,undefined,":{"symbol":"ENGNW","floatShares":51105201,"roa":"-28.90%","roe":"-53.28%","lyrEps":0,"volumeRatio":5.329835,"shares":51105201,"dividePrice":0,"high":3.48,"amplitude":0.036466,"preClose":3.565,"low":3.35,"week52Low":0.51,"pbRate":"1.03","week52High":4.2,"institutionHeld":0,"latestPrice":3.39,"eps":-2.2947,"divideRate":0,"volume":16046,"delay":0,"ttmEps":-2.2947,"open":3.48,"prevYearClose":2.96,"prevWeekClose":3.5001,"prevMonthClose":2.75,"prevQuarterClose":2.96,"fiveDayClose":3.605,"twentyDayClose":3.05,"sixtyDayClose":2.7574},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENGNW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-22","symbol":"ENGNW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1766379600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENGNW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENGNW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.engene.com","stockEarnings":[{"period":"1week","weight":0.0819},{"period":"1month","weight":-0.0618},{"period":"3month","weight":0.2824},{"period":"6month","weight":4.2426},{"period":"1year","weight":3.8836},{"period":"ytd","weight":0.2044}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0165}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.","exchange":"NASDAQ","name":"ENGENE HOLDINGS INC C/WTS 31/10/2028 (TO PUR COM) CL A","nameEN":"ENGENE HOLDINGS INC C/WTS 31/10/2028 (TO PUR COM) CL A"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ENGNW\",market:\"US\",,,undefined,":null}}